On 15 December, the international ROADMAP Consortium who evaluated the usability of multiple data sources for new treatments in Alzheimer’s disease (AD), published an article on challenges in the optimisation of real-world evidence in the journal of Alzheimer’s Disease providing a scientific overview of the project’s endeavours.
You can read the full publication here:
https://www.alzheimersanddementia.com/article/S1552-5260(18)33556-8/pdf